Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4787261
Max Phase: Preclinical
Molecular Formula: C19H24N2O3
Molecular Weight: 328.41
Molecule Type: Unknown
Associated Items:
ID: ALA4787261
Max Phase: Preclinical
Molecular Formula: C19H24N2O3
Molecular Weight: 328.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(=O)c1cccc(-c2ccc(CN3CCN(C)CC3)o2)c1
Standard InChI: InChI=1S/C19H24N2O3/c1-3-23-19(22)16-6-4-5-15(13-16)18-8-7-17(24-18)14-21-11-9-20(2)10-12-21/h4-8,13H,3,9-12,14H2,1-2H3
Standard InChI Key: MWSQNWVDQGXOFZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 328.41 | Molecular Weight (Monoisotopic): 328.1787 | AlogP: 2.87 | #Rotatable Bonds: 5 |
Polar Surface Area: 45.92 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.55 | CX LogP: 2.75 | CX LogD: 2.37 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.79 | Np Likeness Score: -1.26 |
1. Mayer N,Schweiger M,Fuchs E,Migglautsch AK,Doler C,Grabner GF,Romauch M,Melcher MC,Zechner R,Zimmermann R,Breinbauer R. (2020) Structure-activity relationship studies for the development of inhibitors of murine adipose triglyceride lipase (ATGL)., 28 (16): [PMID:32690265] [10.1016/j.bmc.2020.115610] |
Source(1):